Tetsumi Irie

Professor Emeritus & Appointed Professor

Kumamoto University

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Emeritus & Appointed Professor Tetsumi Irie is affiliated with Kumamoto University, Japan. His research focuses on drug development and patient care strategies, particularly in relation to Niemann-Pick Disease and chronic kidney disease. Recent publications have explored innovative approaches in drug therapy and the optimization of prescription practices for patients with specific medical conditions.

Articles (10)

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (9)

Yuki Kondo

Associate Professor

Kumamoto University

JAPAN

View details

Eiichi Araki

JAPAN

View details

Hiroshi Katsuki

Professor

Kumamoto University

JAPAN

View details

Muneaki Matsuo

JAPAN

View details

Yoichi Ishitsuka

Professor

Kumamoto University

JAPAN

View details

Toru Takeo

Professor

Kumamoto University

JAPAN

View details

Takahiro Seki

Visiting Professor

Kumamoto University

JAPAN

View details

Daisuke Kadowaki

Sojo University

JAPAN

View details

Tsuyoshi Shuto

Associate Professor

Kumamoto University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tetsumi Irie

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

In-Hospital Prescription Checking System for Hospitalized Patients with Decreased Glomerular Filtration Rate

Lactose-Appended Hydroxypropyl-β-Cyclodextrin Lowers Cholesterol Accumulation and Alleviates Motor Dysfunction in Niemann-Pick Type C Disease Model Mice

Inclusion Solves Insolubility ―Translational Research Cycle from Bedside to Bench and Bench to Bedside for Drug Development Targeting Niemann-Pick Disease Type C―,Inclusion Solves Insolubility ―Niemann-Pick 病 C 型治療薬開発に関する臨床基礎循環型橋渡し研究―

Differential mode of cholesterol inclusion with 2‐hydroxypropyl‐cyclodextrins increases safety margin in treatment of Niemann‐Pick disease type C

Intracerebroventricular Treatment with 2-Hydroxypropyl-β-Cyclodextrin Decreased Cerebellar and Hepatic Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Expression in Niemann–Pick Disease Type C Model Mice

A homogeneous assay to determine high-density lipoprotein subclass cholesterol in serum

Erratum: Correction to: Awareness and current implementation of drug dosage adjustment by pharmacists in patients with chronic kidney disease in Japan: a web-based survey (BMC health services research (2014) 14 (615))

Improved Formula for Predicting Hemodialyzability of Intravenous and Oral Drugs

Comparative study of constipation exacerbation by potassium binders using a loperamide-induced constipation model

Collaborators (9)

Yuki Kondo

Eiichi Araki

Hiroshi Katsuki

Muneaki Matsuo

Yoichi Ishitsuka

Toru Takeo

Takahiro Seki

Daisuke Kadowaki

Tsuyoshi Shuto

Make your next move.